Clinical trials
Phase 3 Lymphoma, Mantle-Cell trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 5 |
| Active, not recruiting | 4 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Janssen Research & Development, LLC | 3 |
| BeOne Medicines | 2 |
| European Mantle Cell Lymphoma Network | 2 |
| Acerta Pharma BV | 1 |
| Celgene | 1 |
| French Innovative Leukemia Organisation | 1 |
| Loxo Oncology, Inc. | 1 |
| Lymphoma Study Association | 1 |
| Pharmacyclics LLC. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Mantle-Cell | 18 |
| Lymphoma, Non-Hodgkin | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma, Follicular | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Burkitt Lymphoma | 4 |
| Lymphoma | 4 |
| Lymphoma, B-Cell, Marginal Zone | 4 |
| Lymphoma, Large-Cell, Immunoblastic | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.